ASPR, Commerce Department to assess active pharmaceutical ingredient base to better understand pharmaceutical supply chain
![](/https/www.aha.org/sites/default/files/styles/900x400/public/2018-08/woman%20scanning%20drug%20at%20pharmacy.jpg?itok=hewiWrj2)
The Administration for Strategic Preparedness and Response July 16 announced it will work with the Department of Commerce on an assessment of the active pharmaceutical industrial base to better understand the pharmaceutical supply chain and how it has changed since the COVID-19 pandemic. The assessment is based on a survey conducted last winter. The study will inform federal strategies and funding decisions related to the API supply chain and raise awareness of potential supply chain issues, such as the current limited domestic manufacturing capabilities and other potential issues. The study will survey more than 200 companies, including manufacturers, distributors, suppliers and customers. A Bureau of Industry and Security webpage answers FAQs about the project.